Discount Agreement for Dalbavancin (01.06.2026 - 31.05.2028)
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dalbavancin, ATC J01XA04 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Status
Active
Submission Deadline
913 days remaining
Contracting authority
Location
Hamburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-264337-2026
Source
DAK-Gesundheit offers pharmaceutical companies the opportunity to enter into discount agreements for the active ingredient Dalbavancin. This applies to the period from 01.06.2026 to 31.05.2028, with an extension option.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 264337-2026HTML
- TED PDF — 264337-2026PDF
- TED XML — 264337-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024